Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321

Watchlist Manager
Shenzhen Chipscreen Biosciences Co Ltd Logo
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Watchlist
Price: 28.18 CNY 1.22% Market Closed
Market Cap: 11.5B CNY

Relative Value

The Relative Value of one Shenzhen Chipscreen Biosciences Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 28.18 CNY, Shenzhen Chipscreen Biosciences Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shenzhen Chipscreen Biosciences Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
12
Median 3Y
15.4
Median 5Y
18.1
Industry
2.6
Forward
12.2
vs History
9
vs Industry
5
Median 3Y
47.5
Median 5Y
78.9
Industry
21.7
Forward
93
vs History
26
vs Industry
2
Median 3Y
91
Median 5Y
115.3
Industry
16.7
vs History
33
vs Industry
2
Median 3Y
-34.5
Median 5Y
-53.2
Industry
23.1
vs History
46
vs Industry
16
Median 3Y
5.3
Median 5Y
6.6
Industry
2.2
vs History
76
vs Industry
11
Median 3Y
16.9
Median 5Y
18.5
Industry
2.9
Forward
13.5
vs History
74
vs Industry
15
Median 3Y
18.4
Median 5Y
20.4
Industry
5.5
vs History
vs Industry
0
Median 3Y
-114.6
Median 5Y
-102.2
Industry
13.2
Forward
66.3
vs History
vs Industry
0
Median 3Y
-114.6
Median 5Y
-102.2
Industry
16.8
Forward
-204.2
vs History
20
vs Industry
1
Median 3Y
95.4
Median 5Y
124.7
Industry
15.9
vs History
vs Industry
Median 3Y
-32.8
Median 5Y
-47.4
Industry
19.2
vs History
74
vs Industry
26
Median 3Y
3.7
Median 5Y
4.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Shenzhen Chipscreen Biosciences Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
11.5B CNY 13.5 1 578.9 -522.5 -522.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.1 55 36.9 39.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
496.6B USD 5.4 19.8 16.2 21
CH
Roche Holding AG
SIX:ROG
259.2B CHF 4.2 27.5 11.7 13.7
UK
AstraZeneca PLC
LSE:AZN
212B GBP 4.9 30.2 108.4 158.6
CH
Novartis AG
SIX:NOVN
208.2B CHF 4.7 18.2 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.4B USD 3.9 13.2 9.4 11.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.3 10.8
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
CN
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Average P/E: 196.7
1 578.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.8
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.5
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.2
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Average EV/EBITDA: 438.8
Negative Multiple: -522.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
36.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.7
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Average EV/EBIT: 1 881.3
Negative Multiple: -522.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.6
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.7
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.9
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.2
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3